SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-004230
Filing Date
2023-01-20
Accepted
2023-01-20 20:11:40
Documents
1
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2925
  Complete submission text file 0001213900-23-004230.txt   4263
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1751 RIVER RUN, SUITE 400 C/O TFF PHARMACEUTICALS, INC. FORT WORTH TX 76107
Business Address
Mikhak Zamaneh (Reporting) CIK: 0001962453 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39102 | Film No.: 23542310